Spots Global Cancer Trial Database for Physical Functional Side Effects of Taxane Chemotherapy for Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Physical Functional Side Effects of Taxane Chemotherapy for Breast Cancer
Official Title: Physical Functional Side Effects of Taxane Chemotherapy for Breast Cancer
Study ID: NCT01153282
Conditions
Interventions
Study Description
Brief Summary: Determine the characteristics of symptoms and functional impairment associated with chemotherapy induced peripheral neuropathy.
Detailed Description: Taxanes, a type of chemotherapeutic agent prescribed to breast cancer patients, have a known physical side effect of chemotherapy induced peripheral neuropathy (CIPN). The purpose of this qualitative study is to understand the experience and physical functional side effects of taxanes. This is the first of a two phase study. The overall goal is to identify existing objective physical performance measures to assess functional side effects of taxanes.
Keywords
Eligibility
Minimum Age: 21 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Contact Details
Name: Angela DeMichele, MD
Affiliation: Abramson Cancer Center at Penn Medicine
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
